SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001079973-14-000230
Filing Date
2014-03-28
Accepted
2014-03-28 17:11:18
Documents
13
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR THE FISCAL YEAR ENDED 12/31/2013 appy_10k-123113.htm 10-K 1312249
2 EXHIBIT 10.11 ex10x11.htm EX-10.11 6033
3 EXHIBIT 10.15 ex10x15.htm EX-10.15 212808
4 EXHIBIT 23.1 ex23x1.htm EX-23.1 4034
5 EXHIBIT 31.1 ex31x1.htm EX-31.1 16284
6 EXHIBIT 31.2 ex31x2.htm EX-31.2 14886
7 EXHIBIT 32 ex32.htm EX-32 7707
  Complete submission text file 0001079973-14-000230.txt   7537120

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE appy-20131231.xml EX-101.INS 1065230
9 XBRL SCHEMA FILE appy-20131231.xsd EX-101.SCH 45544
10 XBRL CALCULATION FILE appy-20131231_cal.xml EX-101.CAL 47729
11 XBRL DEFINITION FILE appy-20131231_def.xml EX-101.DEF 193246
12 XBRL LABEL FILE appy-20131231_lab.xml EX-101.LAB 682180
13 XBRL PRESENTATION FILE appy-20131231_pre.xml EX-101.PRE 337135
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
Venaxis, Inc. (Filer) CIK: 0001167419 (see all company filings)

IRS No.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33675 | Film No.: 14726743
SIC: 2835 In Vitro & In Vivo Diagnostic Substances